{"id":10342,"date":"2023-08-07T08:22:32","date_gmt":"2023-08-07T07:22:32","guid":{"rendered":"https:\/\/www.ilmelanoma.com\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/"},"modified":"2026-10-17T12:11:18","modified_gmt":"2026-10-17T11:11:18","slug":"rights-of-the-cancer-patient","status":"publish","type":"page","link":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/","title":{"rendered":"Cancer patient rights in Italy: work, support and the right to be forgotten"},"content":{"rendered":"<div class=\"im26-diagnosis-guide im26-care-guide\">\n<p class=\"im26-care-intro\">Italian protections, eligibility and contacts: legal information reviewed on 17 October 2026.<\/p>\n<nav class=\"im26-dg-toc\" aria-label=\"On this page\"><strong>On this page<\/strong><\/p>\n<ol>\n<li><a href=\"#care-riconoscimenti\">Diagnosis, civil disability and Law 104: different assessments<\/a><\/li>\n<li><a href=\"#care-lavoro\">Employment and carers: distinguish the available measures<\/a><\/li>\n<li><a href=\"#care-novita\">Law 106\/2025: new protections<\/a><\/li>\n<li><a href=\"#care-oblio\">The right to be forgotten and practical next steps<\/a><\/li>\n<\/ol>\n<\/nav>\n<section class=\"im26-dg-section\" id=\"care-riconoscimenti\">\n<h2>Diagnosis, civil disability and Law 104: different assessments<\/h2>\n<p>A cancer diagnosis does not automatically confer a disability percentage, recognition under Law 104 or a cash benefit. Civil disability, disability-related support needs and contribution-based benefits involve different assessments. Functional limitations, treatment and assistance needs matter; some financial benefits also depend on age, income or contribution history. Historical percentage tables quoted without context cannot predict an individual decision.<\/p>\n<p>Applications begin with medical certification and follow the INPS procedure applicable to the province. In 2026, disability reform is being introduced progressively across territories. In pilot areas the introductory medical certificate initiates the new procedure; elsewhere the locally applicable application process remains relevant. Check with INPS or a patronato before submitting an unnecessary duplicate claim. Cancer assessments have an accelerated pathway, but a medical assessment deadline is not a promise of payment within fifteen days.<\/p>\n<p>An attendance allowance requires specific loss-of-independence criteria; the diagnosis alone is insufficient. Documented deterioration may justify reassessment. Keep decisions and review dates securely, rather than posting reports on forums or sending them to unidentified services.<\/p>\n<div class=\"im26-dg-gallery im26-care-images\">\n<figure><a href=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg\"><img loading=\"lazy\" src=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg\" width=\"480\" height=\"480\" loading=\"lazy\" decoding=\"async\" alt=\"Image retained from the site archive.\"\/><\/a><figcaption>Image retained from the site archive.<\/figcaption><\/figure>\n<\/div>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.inps.it\/content\/dam\/inps-site\/pdf\/allegatinews\/2025\/diritti_tutele_malattie_oncologiche.pdf\">INPS \u2014 Diritti e tutele in caso di malattie oncologiche, 2025<\/a>; <a href=\"https:\/\/www.inps.it\/it\/it\/inps-comunica\/dossier\/riforma-della-disabilita\/fase-sperimentale.html\">INPS \u2014 Riforma della disabilit\u00e0: fase sperimentale<\/a>.<\/small><\/p>\n<\/section>\n<section class=\"im26-dg-section\" id=\"care-lavoro\">\n<h2>Employment and carers: distinguish the available measures<\/h2>\n<p>The period during which employment is protected during sickness, known as comporto, and the amount paid also depend on the collective agreement. Ask the personnel office for a written calculation before available leave runs out. Law 104 leave requires the appropriate recognition and eligibility. Qualifying employees may use daily or monthly arrangements, while family care has specific rules, including sharing the monthly three-day allowance.<\/p>\n<p>Treatment leave of up to thirty days annually concerns employees with a reduction in working capacity greater than 50% who need treatment related to the recognised impairment. An application and medical documentation are required; it is not informal time off. The right to change to part-time work for cancer-related reduced working capacity requires assessment, with a right to return to full-time employment under the applicable provisions.<\/p>\n<p>Extraordinary leave to care for someone with severe disability has its own family, cohabitation and priority requirements. It differs from the unpaid personal leave introduced by Law 106\/2025. A parking permit depends on certified walking limitations, including temporary limitations: it is not automatically available to every person receiving cancer treatment. A patronato, hospital social worker or occupational physician can help identify the appropriate route.<\/p>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.inps.it\/content\/dam\/inps-site\/pdf\/allegatinews\/2025\/diritti_tutele_malattie_oncologiche.pdf\">INPS \u2014 Diritti e tutele in caso di malattie oncologiche, 2025<\/a>.<\/small><\/p>\n<\/section>\n<section class=\"im26-dg-section\" id=\"care-novita\">\n<h2>Law 106\/2025: new protections<\/h2>\n<p>Subject to Article 1, Law 106\/2025 provides up to twenty-four months of continuous or intermittent leave with job retention after other justified absences have been exhausted. It is unpaid, excludes other work and does not automatically accrue seniority or pension contributions; contribution redemption is provided for. On return, eligible employees have priority access to agile working where their duties allow it.<\/p>\n<p>From 1 January 2026, Article 2 adds ten annual hours for appointments, investigations and treatment, with medical prescription and an allowance governed by the legislation. It covers active cancer or early <a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/\">follow-up<\/a> and the other specified conditions, as well as employees with affected minor children. The text includes a 74% disability threshold: confirm medical eligibility, certification and its application with the employer and patronato rather than assuming every skin check automatically qualifies. For self-employed people working continuously for a client, the law also extends suspension of the service, subject to its conditions, to up to three hundred days annually.<\/p>\n<p>INPS circular 152\/2025 requires at least 74% recognised disability, including for cancer, for private-sector employees insured by INPS. For a minor child, a disability assessment granting at least the attendance allowance satisfies this requirement. Apply to the employer and subsequently provide proof of attendance from the healthcare facility. Leave is taken in whole hours. INPS compensation uses 66.66% of the reference pay; check contractual supplements rather than assuming full pay.<\/p>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.gazzettaufficiale.it\/eli\/id\/2025\/07\/25\/25G00114\/sg\">Legge 18 luglio 2025, n. 106<\/a>; <a href=\"https:\/\/www.flcpn.it\/wp-content\/uploads\/2026\/01\/Circolare_INPS_152_del_19_dicembre_2025_Tutele_per_lavoratori_affetti_da_malattie_oncologiche_invalidanti_e_croniche.pdf\">INPS, circolare 152\/2025, paragrafi 2\u20134 (copia del documento)<\/a>.<\/small><\/p>\n<\/section>\n<section class=\"im26-dg-section\" id=\"care-oblio\">\n<h2>The right to be forgotten and practical next steps<\/h2>\n<p>Law 193\/2023 protects qualifying people against use of their past cancer history in banking, insurance, adoption and access to employment. The general rule concerns treatment completed without recurrence more than ten years earlier, reduced to five for cancers diagnosed before age twenty-one. The decree of 22 March 2024 sets shorter periods for certain cancers: its melanoma category for people over twenty-one specifies six years. A physician must check the starting date, eligibility and certification under the implementing provisions.<\/p>\n<p>This right does not erase clinical information needed for care or mean <a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/\">follow-up<\/a> should stop. Collect medical reports and assessment decisions, ask which certificate is needed, consult a patronato for INPS benefits and a social worker for regional or municipal assistance. Transport, home support and local grants are not uniformly available. Tax deductions have separate rules: consult a CAF or the Italian Revenue Agency. This English page describes Italy, not a universal system, and cannot determine entitlement in an individual case.<\/p>\n<p class=\"im26-dg-sources\"><small>Sources: <a href=\"https:\/\/www.salute.gov.it\/imgs\/C_17_opuscoliPoster_567_allegato.pdf\">Ministero della Salute \u2014 Oblio oncologico<\/a>; <a href=\"https:\/\/www.gazzettaufficiale.it\/eli\/gu\/2024\/04\/24\/96\/sg\/pdf\">Gazzetta Ufficiale 24 aprile 2024 \u2014 DM 22 marzo 2024<\/a>; <a href=\"https:\/\/www.gazzettaufficiale.it\/eli\/id\/2024\/07\/30\/24A03953\/SG\">DM 5 luglio 2024 \u2014 Certificazione dell\u2019oblio oncologico<\/a>.<\/small><\/p>\n<\/section>\n<aside class=\"im26-dg-related\">\n<h2>Continue the pathway<\/h2>\n<div class=\"im26-resource-grid\">\n<article>\n<h3><a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/melanoma-tax-exemptions\/\">Healthcare co-payment exemption 048 for melanoma in Italy<\/a><\/h3>\n<p>How to apply for the Italian cancer-related healthcare exemption and understand its scope.<\/p>\n<\/article>\n<article>\n<h3><a href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/\">After melanoma: follow-up and everyday life<\/a><\/h3>\n<p>A personalised plan for surveillance, symptoms, recovery and support after diagnosis.<\/p>\n<\/article>\n<article>\n<h3><a href=\"https:\/\/www.ilmelanoma.com\/en\/guides\/living\/\">Living with melanoma<\/a><\/h3>\n<p>Follow-up, rights and everyday life: a pathway for patients and those close to them.<\/p>\n<\/article>\n<\/div>\n<\/aside>\n<p class=\"im26-dg-sources\"><small>Editorial review and source consultation: 17 October 2026. Educational information, not individual healthcare or benefits advice. Source checking does not certify a new specialist clinical validation.<\/small><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Italian protections, eligibility and contacts: legal information reviewed on 17 October 2026.<\/p>\n","protected":false},"author":13,"featured_media":0,"parent":10336,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-10342","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rights of the cancer patient - Melanoma<\/title>\n<meta name=\"description\" content=\"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rights of the cancer patient - Melanoma\" \/>\n<meta property=\"og:description\" content=\"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/\" \/>\n<meta property=\"og:site_name\" content=\"Il Melanoma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-17T11:11:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/\",\"name\":\"Rights of the cancer patient - Melanoma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2010\\\/04\\\/diritti-malato-oncologico.jpg\",\"datePublished\":\"2023-08-07T07:22:32+00:00\",\"dateModified\":\"2026-10-17T11:11:18+00:00\",\"description\":\"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2010\\\/04\\\/diritti-malato-oncologico.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2010\\\/04\\\/diritti-malato-oncologico.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/rights-of-the-cancer-patient\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Melanoma\",\"item\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"What to do after melanoma\",\"item\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/melanoma\\\/what-to-do-after-melanoma\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Rights of the cancer patient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/\",\"name\":\"Il Melanoma\",\"description\":\"la guida alla conoscenza, prevenzione e cura del melanoma\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#organization\",\"name\":\"Il Melanoma\",\"alternateName\":\"ilmelanoma.com\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo-melanoma-azzurro.png\",\"contentUrl\":\"https:\\\/\\\/www.ilmelanoma.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/logo-melanoma-azzurro.png\",\"width\":300,\"height\":29,\"caption\":\"Il Melanoma\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ilmelanoma.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rights of the cancer patient - Melanoma","description":"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/","og_locale":"en_US","og_type":"article","og_title":"Rights of the cancer patient - Melanoma","og_description":"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.","og_url":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/","og_site_name":"Il Melanoma","article_modified_time":"2026-10-17T11:11:18+00:00","og_image":[{"url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/","url":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/","name":"Rights of the cancer patient - Melanoma","isPartOf":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/#primaryimage"},"image":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg","datePublished":"2023-08-07T07:22:32+00:00","dateModified":"2026-10-17T11:11:18+00:00","description":"The Italian State recognizes a civil disability for cancer patients: 11% - favorable prognosis and modest functional impairment; 70% - favorable prognosis, but severe functional impairment; 100% - poor or possibly unfavorable prognosis.","breadcrumb":{"@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/#primaryimage","url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg","contentUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2010\/04\/diritti-malato-oncologico.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/rights-of-the-cancer-patient\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Melanoma","item":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/"},{"@type":"ListItem","position":2,"name":"What to do after melanoma","item":"https:\/\/www.ilmelanoma.com\/en\/melanoma\/what-to-do-after-melanoma\/"},{"@type":"ListItem","position":3,"name":"Rights of the cancer patient"}]},{"@type":"WebSite","@id":"https:\/\/www.ilmelanoma.com\/en\/#website","url":"https:\/\/www.ilmelanoma.com\/en\/","name":"Il Melanoma","description":"la guida alla conoscenza, prevenzione e cura del melanoma","publisher":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ilmelanoma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ilmelanoma.com\/en\/#organization","name":"Il Melanoma","alternateName":"ilmelanoma.com","url":"https:\/\/www.ilmelanoma.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ilmelanoma.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2023\/06\/logo-melanoma-azzurro.png","contentUrl":"https:\/\/www.ilmelanoma.com\/wp-content\/uploads\/2023\/06\/logo-melanoma-azzurro.png","width":300,"height":29,"caption":"Il Melanoma"},"image":{"@id":"https:\/\/www.ilmelanoma.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/10342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/comments?post=10342"}],"version-history":[{"count":1,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/10342\/revisions"}],"predecessor-version":[{"id":11145,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/10342\/revisions\/11145"}],"up":[{"embeddable":true,"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/pages\/10336"}],"wp:attachment":[{"href":"https:\/\/www.ilmelanoma.com\/en\/wp-json\/wp\/v2\/media?parent=10342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}